Predictions
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€69.30
21.01.21
21.01.21
-
21.01.22
21.01.22
17.39%
29.06.21
29.06.21
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€39.13
11.01.21
11.01.21
€50.00
11.01.22
11.01.22
-5.37%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€22.25
11.01.21
11.01.21
€75.00
11.01.22
11.01.22
65.17%
25.01.21
25.01.21
Could be worthwhile Investment >10% per year
Medtronic plc
Start price
Target price
Perf. (%)
€97.71
10.01.21
10.01.21
-
10.01.22
10.01.22
-2.05%
11.01.22
11.01.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Known brand
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€39.22
04.01.21
04.01.21
€75.00
04.01.22
04.01.22
11.33%
05.09.21
05.09.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Hologic Inc.
Start price
Target price
Perf. (%)
€60.00
31.12.20
31.12.20
€78.00
31.12.21
31.12.21
10.17%
01.01.22
01.01.22
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Hologic Inc.
Start price
Target price
Perf. (%)
€60.00
31.12.20
31.12.20
€78.00
31.12.21
31.12.21
10.17%
01.01.22
01.01.22
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Stratec SE
Start price
Target price
Perf. (%)
€122.40
30.12.20
30.12.20
€128.00
30.12.21
30.12.21
12.75%
31.12.21
31.12.21
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€13.00
14.12.20
14.12.20
€25.00
14.12.21
14.12.21
71.15%
11.01.21
11.01.21
Could be worthwhile Investment >10% per year
Nanostr.technol.
Start price
Target price
Perf. (%)
€57.50
13.12.20
13.12.20
-
13.12.21
13.12.21
-41.91%
14.12.21
14.12.21
Risky Investment
iRhythm Technologies Inc
Start price
Target price
Perf. (%)
€151.00
02.12.20
02.12.20
-
02.12.21
02.12.21
-42.05%
03.12.21
03.12.21
Risky Investment
Genmark Diagnostics
Start price
Target price
Perf. (%)
€11.10
30.11.20
30.11.20
€14.00
30.11.21
30.11.21
-7.21%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€13.50
30.11.20
30.11.20
€15.00
30.11.21
30.11.21
31.85%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€21.00
30.11.20
30.11.20
€25.00
30.11.21
30.11.21
-15.71%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
30.11.20
30.11.20
€7.00
30.11.21
30.11.21
-
14.12.20
14.12.20
Could be very worthwhile Investment >20% year
Teleflex Inc.
Start price
Target price
Perf. (%)
€308.00
20.11.20
20.11.20
-
20.11.21
20.11.21
8.44%
14.02.21
14.02.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Genmark Diagnostics
Start price
Target price
Perf. (%)
€11.50
16.11.20
16.11.20
€13.00
16.11.21
16.11.21
-3.48%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€13.20
16.11.20
16.11.20
€15.00
16.11.21
16.11.21
2.27%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€18.10
16.11.20
16.11.20
€20.00
16.11.21
16.11.21
16.02%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
16.11.20
16.11.20
€7.00
16.11.21
16.11.21
-
30.11.20
30.11.20
Could be very worthwhile Investment >20% year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.97
12.11.20
12.11.20
€50.00
12.11.21
12.11.21
21.49%
13.07.21
13.07.21
Top 10 in its market
Small cyclical dependencies
Below average Management
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€34.41
09.11.20
09.11.20
€40.00
09.11.21
09.11.21
18.27%
02.11.21
02.11.21
Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Humana Inc.
Start price
Target price
Perf. (%)
€364.00
03.11.20
03.11.20
-
04.11.21
04.11.21
-6.04%
14.01.21
14.01.21
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
Misonix Inc.
Start price
Target price
Perf. (%)
€9.55
02.11.20
02.11.20
€11.00
04.11.21
04.11.21
4.19%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year